MyChesCo on MSN18d
Annovis Bio to Present Key Alzheimer’s Research at CTAD Conference
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is gearing up to showcase critical research at the 17th Clinical Trials on ...
The Bakersfield Californian10d
Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with ...
Baseline characteristics of the 130 participants enrolled in the study, as described in the poster: “DLB is one of the most common forms of dementia and a complex neurological condition. Symptoms ...
Yahoo Finance1mon
NKGen Biotech Announces Poster Presentations at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Full abstracts accepted as poster presentations will also be included in the special CTAD edition of the Journal of Prevention of Alzheimer’s Disease (JPAD), the official journal of the CTAD ...
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...
The Bakersfield Californian1mon
NKGen Biotech Announces Poster Presentations at the 17th Annual Clinical Trials on Alzheimer’s ...
today announced upcoming poster presentations on a final report of a Phase 1 dose escalation study and on a preliminary report of the Phase 1 cohort in the follow-up Phase 1/2a study of ...